Neumora Therapeutics, Inc.
NMRA
$1.20
-$0.05-4.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 116.83M | 147.07M | 182.53M | 171.53M | 217.59M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.04M | 6.36M | 8.01M | 5.56M | 5.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 124.87M | 153.43M | 190.54M | 177.08M | 222.91M |
|
|
|||||
| Total Current Assets | 124.87M | 153.43M | 190.54M | 177.08M | 222.91M |
| Net Property, Plant & Equipment | 322.00K | 390.00K | 457.00K | 554.00K | 618.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.00K | 53.00K | 53.00K | 197.00K | 298.00K |
| Total Assets | 125.25M | 153.88M | 191.05M | 177.83M | 223.83M |
|
|
|||||
| Total Accounts Payable | 4.15M | 5.06M | 3.38M | 549.00K | 644.00K |
| Total Accrued Expenses | 20.26M | 22.44M | 28.79M | 24.98M | 20.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 299.00K | 291.00K | 284.00K | 256.00K | 171.00K |
| Total Finance Division Other Current Liabilities | 3.07M | 2.32M | -- | 55.00K | 88.00K |
| Total Other Current Liabilities | 3.07M | 2.32M | -- | 55.00K | 88.00K |
| Total Current Liabilities | 27.78M | 30.12M | 32.45M | 25.84M | 21.16M |
|
|
|||||
| Total Current Liabilities | 27.78M | 30.12M | 32.45M | 25.84M | 21.16M |
| Long-Term Debt | 52.91M | 52.96M | 54.53M | 19.56M | 19.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 41.00K | 119.00K | 193.00K | 267.00K | 339.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 80.73M | 83.20M | 87.18M | 45.67M | 40.95M |
|
|
|||||
| Common Stock & APIC | 1.33B | 1.31B | 1.29B | 1.26B | 1.25B |
| Retained Earnings | -1.28B | -1.24B | -1.18B | -1.12B | -1.07B |
| Treasury Stock & Other | -- | -- | -- | 9.00K | -15.00K |
| Total Common Equity | 44.52M | 70.68M | 103.87M | 132.16M | 182.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 44.52M | 70.68M | 103.87M | 132.16M | 182.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 44.52M | 70.68M | 103.87M | 132.16M | 182.88M |
|
|
|||||